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DING proteins constitute an intriguing family of phosphate-binding proteins
that was identiﬁed in a wide range of organisms, from prokaryotes and archae
to eukaryotes. Despite their seemingly ubiquitous occurrence in eukaryotes,
their encoding genes are missing from sequenced genomes. Such a lack has
considerably hampered functional studies. In humans, these proteins have been
related to several diseases, like atherosclerosis, kidney stones, inﬂammation
processes and HIVinhibition. The human phosphate binding protein is a human
representative of the DING family that was serendipitously discovered from
human plasma. An original approach was developed to determine ab initio
the complete and exact sequence of this 38 kDa protein by utilizing mass
spectrometry and X-ray data in tandem. Taking advantage of this ﬁrst complete
eukaryotic DING sequence, a immunohistochemistry study was undertaken to
check the presence of DING proteins in various mice tissues, revealing that
these proteins are widely expressed. Finally, the structure of a bacterial
representative from Pseudomonas ﬂuorescens was solved at sub-angstrom
resolution, allowing the molecular mechanism of the phosphate binding in these
high-afﬁnity proteins to be elucidated.
Keywords: serendipity; DING protein; ab initio sequencing; sub-angstrom crystallography;
HIV inhibition.
1. The DING proteins
DING proteins constitute an intriguing family of phosphate-
binding proteins named DING according to their four
conserved N-terminal residues (Berna et al., 2002). Surpris-
ingly, the genes coding for these proteins are systematically
missing from eukaryotic sequenced genomes, despite the fact
that these proteins seem ubiquitous in eukaryotes, being
isolated in animals (human, monkey, rat, turkey), in plants
(Arabidopsis thaliana, potato, tobacco) and in fungi (Candida
albicans, Ganoderma lucidum) (Berna et al., 2002; Riah et al.,
2000; Belenky et al., 2003; Blass et al., 1999; Kumar et al., 2004;
Adams et al., 2002; Weebadda et al., 2001; Scott & Wu, 2005;
Morales et al., 2006; Du et al., 2007; Chen et al., 2007).
Furthermore, the DING proteins family extends to prokar-
yotes (Berna et al., 2008), as some representatives and their
corresponding genes have been identiﬁed in Pseudomonads
(Ahn et al., 2007), whereas in some other bacteria the
encoding gene remains unidentiﬁed (Pantazaki et al., 2008). In
eukaryotes, partial DNA sequences coding for this protein
family have been cloned or identiﬁed in unannotated parts of
genomes (Berna et al., 2008; Berna, Bernier et al., 2009), and
another interesting point in genetics concerns the sequence
conservation. Indeed, between distant species such as potato
(a higher plant) and Leishmania major (a protozoan) the
sequence identity between the known DING representatives
is about 90% at the nucleotidic level, over more than 600 base
pairs (Morales et al., 2006). This high conservation raised
controversy about their prokaryotic (Lewis & Crowther, 2005)
or eukaryotic origins (Berna, Scott et al., 2009).
DING proteins have been mostly isolated by virtue of a
biological function. One of the best illustrations is the search
for a new HIV inhibitor in St John’s wort that led to the
characterization of a novel DING protein named p27
sj
(Darbinian-Sarkissian et al., 2006). In humans, several DING
proteins have been identiﬁed from different tissues, including
the crystal adhesion inhibitor (CAI), the human synovial
stimulatory protein (SSP), X-DING-CD4+ from human CD4+
T lymphocytes and the human phosphate binding protein
(HPBP). Comparison of available peptides sequences of
HPBP, CAI, SSP and X-DING-CD4+ strongly suggests that
these proteins are encoded by four different genes, all lacking
the sequenced human genome. The CAI, isolated from human
kidney cells, is assumed to prevent the growth of kidney stones
(Kumar et al., 2004). The SSP, isolated from human synovial
liquid, possesses auto-antigen activity, lymphocyte stimulatory
activity and a putative role in the etiology of rheumatoid
arthritis (Hain et al., 1990, 1996). X-DING-CD4+ was isolated
from CD4+ T cells that are resistant to HIV infection and was
shown to block the HIV-1 LTR promoted expression and thereplication of HIV-1 (Lesner et al., 2009). HPBP is a seren-
dipitously discovered plasma lipoprotein that binds phosphate
and was isolated from human plasma (Fokine et al., 2003;
Contreras-Martel et al., 2006). HPBP structure was solved
(Morales et al., 2006) and its physiological function, i.e. its
association with the paraoxonase (HPON1), an enzyme
involved in atherosclerosis (Shih et al., 1998), has been
extensively studied (Renault et al., 2010; Rochu et al., 2008;
Rochu, Renault et al., 2007; Rochu, Chabriere et al., 2007). The
involvement of DING proteins in a large spectrum of diseases
enhances the potential therapeutic value of this speciﬁc
protein family, but the lack of sequences has considerably
hampered the functional studies within this protein family.
2. Ab initio sequencing of HPBP
HPBP is a plasmatic protein interacting with HPON1 and
possibly involved in inﬂammation and atherosclerosis
processes (Webb, 2006). HPBP was serendipitously discovered
while performing structural studies on supposedly pure
HPON1 samples puriﬁed from human plasma. Crystals were
obtained and the resolved structure was not that of HPON1
but rather that of an unexpected and unknown protein: HPBP.
As for other DING proteins, the lack of genetic sequence
encoding for HPBP has considerably hindered functional
studies. In order to overcome this difﬁculty, HPBP’s sequence
was determined experimentally. However, the ab initio
sequencing of a protein of 38 kDa is not a trivial task, and can
barely be achieved using only one technique, i.e. mass spec-
trometry, mainly because some of the protein peptides are too
hydrophobic and barely observed in this experiment. A new
strategy was developed, utilizing mass spectrometry sequen-
cing and available X-ray data in tandem (Diemer et al., 2008).
2.1. Limitations of the X-ray sequencing
The ﬁrst HPBP sequence was inferred from electronic
density maps at 1.9 A ˚ (Fig. 1a). However, this sequence
contains some ambiguities. The electronic density map is
related to the electron number of the atoms, but at this
resolution it is not possible to clearly discriminate C, N and O
atoms as they possess roughly the same number of electrons
(six, seven and eight electrons, respectively). This limitation
implies that some amino acids possess similar electronic
density shapes at such a resolution, such as Asn and Asp, Gln
and Glu, and Val and Thr (Fig. 1b), and are thus difﬁcult
to discriminate. Furthermore, some protein residues possess
multiple conformations. Agitation modiﬁes the electronic
density shape. As an illustration, a double serine conformation
causes similar electronic density shapes as threonine or valine
residues (Fig. 1c). A third cause of ambiguity concerns dis-
ordered atoms. Indeed, disordered atoms contribute less than
ordered atoms in diffraction. Consequently, these agitated
atoms disappear from the electronic density maps. This mainly
concerns residues located at the protein extremities or surface,
and causes truncated electronic density, which can be assimi-
lated to the density corresponding to shorter residue (Fig. 1d).
2.2. Combination of X-ray data and mass spectrometry data
Aseriesof enzymatic digestions was performed on HPBP to
generate peptides, allowing a maximum of sequence infor-
mation by mass spectrometry (MS) fragmentation in LC-MS/
MS and MALDI-MS/MS experiments to be obtained. The
primary sequence obtained by X-ray crystallography was used
like an ‘Ariane wire’, useful to align peptide sequences
subsequently obtained by mass spectrometry, without the
need of having overlapping peptides. It can be noted that
X-ray crystallography techniques provided important infor-
mation that can barely be obtained using MS, such as the exact
number of amino acids and the presence of the disulﬁde
bridges, and the discrimination of residues that possess the
same mass (Leu, Ile, etc.). MS experiments, including ESI-MS
on intact HPBP, were used to correct errors from crystal-
lographic sequencing, including those for the few peptides that
could not be sequenced. Finally, this technique allowed,
ab initio and without ambiguities, the 38 kDa HPBP to be
sequenced (Diemer et al., 2008), showing that this method
could be applied to other DING proteins.
3. The tissue localization of DING proteins
Taking advantage of obtaining the HPBP sequence (Diemer et
al., 2008), several polyclonal and monoclonal antibodies
targeted against HPBP were developed. Because of the very
high sequence identity between DING proteins sequences, the
polyclonal antibodies are able to cross-react with other DING
proteins. This property was used to map the DING proteins
localization in several mouse tissues by immunohistochem-
istry.
DING proteins were observed in all tested tissues, namely
brain, skin, heart, aorta, lung and liver, suggesting that these
proteins are widely expressed within the organism (Collombet
et al., 2010). A western blot study on these samples also
conﬁrms previous assumptions, stemming from the partial
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Figure 1
(a) Close view of a ball-and-stick representation of the R374 region in the
HPBP structure at 1.9 A ˚ resolution. The 2fobs  fcalc electronic density
map is contoured at 1.75.( b) Comparison between the electronic
density shapes of N103 and D318. The 2fobs  fcalc electronic density map
is contoured at 1.5.( c) Comparison between electronic density shapes of
V350, T313 and S143. The 2fobs  fcalc electronic density map is contoured
at 1.5.( d) Comparison between the electronic density shapes of N238
and S32. The 2fobs  fcalc electronic density map is contoured at 1.5.gene found in Leishmania major genome and western blot
studies on plant tissues (Perera et al., 2008), suggesting that
DING proteins exists also as high-molecular-weight proteins
(HMW-DING). Indeed, if most of the characterized DING
proteins are 38 kDa proteins, our western blot study shows
that several HMW-DINGs exists, such as the 140 kDa, the
71 kDa, the 62 kDa and the 52 kDa DING (Collombet et al.,
2010). The presence of several isoforms of DING proteins
might be linked with different biological activities. Indeed,
it was shown for a bacterial DING representative named
PﬂuDING that the truncated form possesses higher stimula-
tion effects on human ﬁbroblasts proliferation than the
38 kDa form (Ahn et al., 2007). This result suggests that there
is still a lot to do to understand the physiological involvements
of these putatively uncharacterized proteins.
The immunohistochemistry study also reveals that the
DING protein cellular localization is tissue-dependent, being
exclusively nuclear in neurons, and nuclear and cytoplasmic in
the heart muscle. The nuclear localization of DING proteins
ﬁts well with previous observations concerning biological
activities of DING proteins, showing a clear involvement of
these proteins in complex processes within the nucleus. For
example, p27
SJ suppresses expression of HIV-1 genome
(Darbinian et al., 2008). This suppression of expression is
mediated by the physical and functional association of p27
SJ
with human C/EBP transcription factor and viral Tat trans-
activator. Moreover, p27
SJ possesses a phosphatase activity
inducing a dysregulation at S and G2/M phases in cell cycles
related to alteration of the Erk1/2 phosphorylation state
(Darbinian et al., 2009). In addition, X-DING-CD4+ seems to
interact with transcription factors in the nucleus, and is
believed to be involved in the resistance to HIV infection of
non-progressive patients (Lesner et al., 2005, 2009).
4. The structure of DING proteins
Two structures of DING representatives are available: the
structure of HPBP (Morales et al., 2006) and the structure of a
bacterial representative from Pseudomonas ﬂuorescens called
PﬂuDING (Ahn et al., 2007; Moniot et al., 2007). These two
structures conﬁrm the ability of these proteins to bind a single
phosphate ion, in the same manner as the bacterial pstS, which
sequesters phosphate for cellular uptake by the ABC phos-
phate transporter. These two structures and the pstS ﬁt a
model known as the ‘Venus ﬂytrap’, in which the structure can
adopt an open and a closed form depending on the phosphate
binding (Luecke & Quiocho, 1990). The DING proteins
structures reveal an elongated fold composed of two globular
domains (Fig. 2a). Each domain constitutes a central -sheet
core ﬂanked by -helices and contains a disulﬁde bridge that is
conserved among the family. Interconnected by an antiparallel
two-stranded -sheet acting as a hinge, the two domains form
a deep cleft wherein a phosphate molecule is bound. This fold,
known as the Venus ﬂytrap, is very similar to those of the sixth
family of solute binding proteins (SBP) (Felder et al., 1999).
Structural superposition shows a high correspondence
between PﬂuDING, HPBP and the Escherichia coli phos-
phate-binding protein. Interestingly, the unique feature of
DING proteins compared with pstS is the presence of four
protruding loops at the protein surface (Fig. 2b).
5. Elucidation of the phosphate-binding mechanism
Although their phosphate-binding ability has not been clearly
related to their biological functions until now, DING proteins
are able to bind phosphate with high afﬁnity. Indeed, it has
been shown that HPBP and PﬂuDING bind phosphate with
a KD of approximately 1 mM (Ahn et al., 2007; Luecke &
Quiocho, 1990), of the same order as bacterial phosphate
solute binding protein (Poole & Hancock, 1984; Luecke &
Quiocho, 1990). As PﬂuDING yields crystals diffracting to
very high resolution, it offers the most convenient model for
investigating the molecular mechanism of the phosphate
binding in these high-afﬁnity binding proteins. The sub-
angstrom resolution structures of PﬂuDING (0.98 A ˚ and
0.88 A ˚ ) at two different pH values (4.5 and 8.5) have been
successfully obtained (Liebschner et al., 2009).
The quality of the obtained data allows most of the H atoms
in the protein structure to be located precisely (Fig. 3a).
Moreover, the H atoms involved in the binding of the phos-
phate ion are clearly visible in both structures. Surprisingly,
and despite the intrinsic pKa values of the phosphate moiety,
PﬂuDING binds only dibasic phosphate both at acidic and
basic pH. The structures show that the phosphate ion is bound
via 11 normal hydrogen bonds plus a highly energetic
hydrogen bond, between a phosphate oxygen and the
carboxylate side chain of Asp62 (Fig. 3b). This very short bond
(2.50 A ˚ ) belongs to the low barrier hydrogen bond (LBHB)
type, where the H atom is almost perfectly shared between the
two heavy atoms. This work, combined with electrostatic
potential computations, demonstrates the capacity of the
protein to alter the pKa of atoms in the binding site. Indeed,
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Figure 2
(a) X-ray structure of HPBP. The two globular domains are shown in pink
and blue. They are hinged by an antiparallel two-stranded -sheet acting
as a hinge (in yellow), and form a deep cleft wherein a phosphate
molecule is bound (red balls). The two disulﬁde bridges (C113–C158 and
C306–C359) are shown by orange sticks. (b) Structural comparison of
different known phosphate-SBPs: HPBP [Protein Data Bank (PDB) ID:
2v3q] is shown in blue, PﬂuDING (PDB ID: 2q9t) is shown in yellow,
E. coli PstS protein (PDB ID: 1ixh) is shown in red. The four protruding
DING protein-speciﬁc loops are indicated by black arrows.the fact that PﬂuDING binds only dibasic phosphate both at
acidic and basic pH can be explained by the ﬁnding of a very
positively charged binding site, capable of altering dramati-
cally the phosphate pKa.
6. Conclusion
The DING proteins family is an intriguing protein family that
seems ubiquitous in eukaryotes, albeit their coding genes are
missing. This unconventional protein family requires, for
its investigation, some methodological developments. For
example, an original approach was developed in order to
sequence ab initio HPBP using mass spectrometry and X-ray
data in tandem. Taking advantage of the very high diffracting
power of DING protein crystals, we elucidated the molecular
mechanism of phosphate binding in high-afﬁnity proteins.
These studies illustrate that DING proteins are widely
expressed in eukaryotic tissues, and their cellular localization
is tissue-dependent, albeit being mostly nuclear. This nuclear
localization partly explains some observed biological activ-
ities, such as the role in the cell cycle and the inhibition of the
HIV replication by interacting with the viral protein Tat and
the human transcription factor CEBP/. The involvement of
DING proteins in several important human diseases, together
with their genetic mystery and our ﬁndings of unknown HMW-
DING in eukaryotes, enhance the emerging scientiﬁc interest
on this protein family.
ME is a Fellow supported by the FEBS. DL is a doctoral
fellow supported by the French Ministry of Research. GG is a
doctoral fellow supported by the DGA. EC is supported by a
grant from the DGA (grant REI no. 09C7002).
References
Adams, L., Davey, S. & Scott, K. (2002). Biochim. Biophys. Acta,
1586, 254–264.
Ahn, S., Moniot, S., Elias, M., Chabriere, E., Kim, D. & Scott, K.
(2007). FEBS Lett. 581, 3455–3460.
Belenky, M., Prasain, J., Kim, H. & Barnes, S. (2003). J. Nutr. 133,
2497S–2501S.
Berna, A., Bernier, F., Chabriere, E., Elias, M., Scott, K. & Suh, A.
(2009). Cell Mol. Life Sci. 66, 2205–2218.
Berna, A., Bernier, F., Chabriere, E., Perera, T. & Scott, K. (2008).
Intl. J. Biochem. Cell Biol. 40, 170–175.
Berna, A., Bernier, F., Scott, K. & Stuhlmuller, B. (2002). FEBS Lett.
524, 6–10.
Berna, A., Scott, K., Chabriere, E. & Bernier, F. (2009). Bioessays, 31,
570–580.
Blass, S., Schumann, F., Hain, N. A., Engel, J. M., Stuhlmuller, B. &
Burmester, G. R. (1999). Arthritis Rheum. 42, 971–980.
Chen, Z., Franco, C. F., Baptista, R. P., Cabral, J. M., Coelho, A. V.,
Rodrigues, C. J. Jr & Melo, E. P. (2007). Appl. Microbiol.
Biotechnol. 73, 1306–1313.
Collombet, J. M., Elias, M., Gotthard, G., Four, E., Renault, F., Joffre,
A., Baubichon, D., Rochu, D. & Chabriere, E. (2010). PLoS One, 5,
e9099.
Contreras-Martel, C., Carpentier, P., Morales, R., Renault, F.,
Chesne-Seck, M.-L., Rochu, D., Masson, P., Fontecilla-Camps,
J. C. & Chabrie `re, E. (2006). Acta Cryst. F62, 67–69.
Darbinian, N., Czernik, M., Darbinyan, A., Elias, M., Chabriere, E.,
Bonasu, S., Khalili, K. & Amini, S. (2009). J. Cell Biochem. 107,
400–407.
Darbinian, N., Popov, Y., Khalili, K. & Amini, S. (2008). Antiviral Res.
79, 136–141.
Darbinian-Sarkissian, N., Darbinyan, A., Otte, J., Radhakrishnan, S.,
Sawaya, B. E., Arzumanyan, A., Chipitsyna, G., Popov, Y.,
Rappaport, J., Amini, S. & Khalili, K. (2006). Gene Ther. 13,
288–295.
Diemer, H., Elias, M., Renault, F., Rochu, D., Contreras-Martel, C.,
Schaeffer, C., Van Dorsselaer, A. & Chabriere, E. (2008). Proteins,
71, 1708–1720.
Du, M., Zhao, L., Li, C., Zhao, G. & Hu, X. (2007). Eur. Food Res.
Technol. 224, 659–665.
Felder, C. B., Graul, R. C., Lee, A. Y., Merkle, H. P. & Sadee, W.
(1999). AAPS PharmSci. 1, E2.
Fokine, A., Morales, R., Contreras-Martel, C., Carpentier, P.,
Renault, F., Rochu, D. & Chabriere, E. (2003). Acta Cryst. D59,
2083–2087.
Hain, N., Alsalameh, S., Bertling, W. M., Kalden, J. R. & Burmester,
G. R. (1990). Rheumatol. Intl. 10, 203–210.
Hain, N. A., Stuhlmuller, B., Hahn, G. R., Kalden, J. R., Deutzmann,
R. & Burmester, G. R. (1996). J. Immunol. 157, 1773–1780.
Kumar, V., Yu, S., Farell, G., Toback, F. G. & Lieske, J. C. (2004). Am.
J. Physiol. 287, F373–F383.
Lesner, A., Li, Y., Nitkiewicz, J., Li, G., Kartvelishvili, A.,
Kartvelishvili, M. & Simm, M. (2005). J. Immunol. 175, 2548–
2554.
diffraction structural biology
48 Mikael Elias et al.  DING proteins J. Synchrotron Rad. (2011). 18, 45–49
Figure 3
(a) Close view of phosphate O4 in the PﬂuDING structure obtained at
pH 4.5. The Fobs  Fcalc map is contoured at 2.6.( b) Experimentally
determined hydrogen bond network involving the phosphate molecule
bound in the PﬂuDING structure.Lesner, A., Shilpi, R., Ivanova, A., Gawinowicz, M. A., Lesniak, J.,
Nikolov, D. & Simm, M. (2009). Biochem. Biophys. Res. Commun.
389, 284–289.
Lewis, A. P. & Crowther, D. (2005). FEMS Microbiol. Lett. 252, 215–
222.
Liebschner, D., Elias, M., Moniot, S., Fournier, B., Scott, K., Jelsch, C.,
Guillot, B., Lecomte, C. & Chabriere, E. (2009). J. Am. Chem. Soc.
131, 7879–7886.
Luecke, H. & Quiocho, F. A. (1990). Nature (London), 347, 402–406.
Moniot, S., Elias, M., Kim, D., Scott, K. & Chabriere, E. (2007). Acta
Cryst. F63, 590–592.
Morales, R., Berna, A., Carpentier, P., Contreras-Martel, C., Renault,
F., Nicodeme, M., Chesne-Seck, M. L., Bernier, F., Dupuy, J.,
Schaeffer, C., Diemer, H., Van-Dorsselaer, A., Fontecilla-Camps,
J. C., Masson, P., Rochu, D. & Chabriere, E. (2006). Structure, 14,
601–609.
Pantazaki, A. A., Tsolkas, G. P. & Kyriakidis, D. A. (2008). Amino
Acids, 34, 437–448.
Perera, T., Berna, A., Scott, K., Lemaitre-Guillier, C. & Bernier, F.
(2008). Phytochemistry, 69, 865–872.
Poole, K. & Hancock, R. E. (1984). Eur. J. Biochem. 144, 607–612.
Renault, F., Carus, T., Clery-Barraud, C., Elias, M., Chabriere, E.,
Masson, P. & Rochu, D. (2010). J. Chromatogr. 878, 1346–1355.
Riah, O., Dousset, J. C., Boﬁll-Cardona, E. & Courriere, P. (2000).
Cell. Mol. Neurobiol. 20, 653–664.
Rochu, D., Chabriere, E., Elias, M., Renault, F., Clery-Barraud, C. &
Masson, P. (2008). The Paraoxonases: Their Role in Disease
Development and Xenobiotic Metabolism, pp. 171–183. Dordrecht:
Springer.
Rochu, D., Chabriere, E., Renault, F., Elias, M., Clery-Barraud, C. &
Masson, P. (2007). Biochem. Soc. Trans. 35, 1616–1620.
Rochu, D., Renault, F., Elias, M., Hanne, S., Cle ´ry-Barraud, C.,
Chabriere, E. & Masson, P. (2007). Toxicology, 142.
Scott, K. & Wu, L. (2005). Biochim. Biophys. Acta, 1744, 234–244.
Shih, D. M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., Hama, S.,
Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M. &
Lusis, A. J. (1998). Nature (London), 394, 284–287.
Webb, M. R. (2006). Structure, 14, 391–392.
Weebadda, W. K., Hoover, G. J., Hunter, D. B. & Hayes, M. A. (2001).
Compar. Biochem. Physiol. 130, 299–312.
diffraction structural biology
J. Synchrotron Rad. (2011). 18, 45–49 Mikael Elias et al.  DING proteins 49